or Try an Advanced Search...

    Technical Analysis for NLSP - NLS Pharmaceutics Ltd.

    Grade Last Price % Change Price Change
    D 0.20 -9.50% -0.02
    NLSP closed down 9.5 percent on Monday, July 1, 2024, on 16 percent of normal volume.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Down
    Historical NLSP trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Down Weakness 0.00%
    180 Bullish Setup Bullish Swing Setup -9.50%
    Calm After Storm Range Contraction -9.50%
    Wide Bands Range Expansion -9.50%
    Gapped Down Weakness -9.50%
    Stochastic Buy Signal Bullish -18.21%
    Older End-of-Day Signals for NLSP ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 6 hours ago
    60 Minute Opening Range Breakdown about 8 hours ago
    10 DMA Support about 9 hours ago
    60 Minute Opening Range Breakout about 10 hours ago
    10 DMA Resistance about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    NLSP Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of drug therapies to treat rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its two lead product candidates, include Quilience, for the treatment of excessive daytime sleepiness and cataplexy; and Nolazol, for the treatment of ADHD. NLS Pharmaceutics AG was founded in 2015 and is based in Stans, Switzerland.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Neurological Disorders Psychiatric Diagnosis Psychiatry Sleep Disorders Attention Deficit Hyperactivity Disorder Drug Therapies Narcolepsy Amphetamine Methylphenidate Adhd Cataplexy Idiopathic Hypersomnia

    Is NLSP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 28 NLS Pharmaceutics looks to raise $0.79M via securities offering
    Jun 28 NLS Pharmaceutics Announces Registered Direct Offering
    Jun 27 Top Midday Gainers
    Jun 27 NLS Pharmaceutics Announces Promising Preclinical Results for Parkinson's Disease Treatments
    Jun 25 Nasdaq Panel Grants NLS Pharmaceutics' Request for Extension to Comply with Continued Listing Requirements
    Jun 20 Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Jun 18 Why Chegg Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
    Jun 11 NLS Pharmaceutics Announces Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide Orexin Receptor Agonists (DOXA)
    May 28 NLS Pharmaceutics Reports Positive Results from Study KO-874 on Mazindol’s Neuroprotective Effects in Narcoleptic-like Rat Model
    May 24 NLS Pharmaceutics receives non-compliance notice from Nasdaq
    See more NLSP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.53
    52 Week Low 0.1112
    Average Volume 11,803,405
    200-Day Moving Average 0.40
    50-Day Moving Average 0.15
    20-Day Moving Average 0.16
    10-Day Moving Average 0.20
    Average True Range 0.05
    RSI (14) 54.34
    ADX 40.14
    +DI 54.63
    -DI 15.40
    Chandelier Exit (Long, 3 ATRs) 0.30
    Chandelier Exit (Short, 3 ATRs) 0.27
    Upper Bollinger Bands 0.25
    Lower Bollinger Band 0.08
    Percent B (%b) 0.7
    BandWidth 105.17
    MACD Line 0.02
    MACD Signal Line 0.01
    MACD Histogram 0.0062
    Fundamentals Value
    Market Cap 7 Million
    Num Shares 35.7 Million
    EPS -0.50
    Price-to-Earnings (P/E) Ratio -0.39
    Price-to-Sales 0.00
    Price-to-Book 4.84
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.22
    Resistance 3 (R3) 0.22 0.21 0.22
    Resistance 2 (R2) 0.21 0.21 0.21 0.22
    Resistance 1 (R1) 0.20 0.20 0.21 0.20 0.21
    Pivot Point 0.20 0.20 0.20 0.20 0.20
    Support 1 (S1) 0.19 0.19 0.19 0.19 0.18
    Support 2 (S2) 0.18 0.19 0.18 0.18
    Support 3 (S3) 0.17 0.18 0.18
    Support 4 (S4) 0.17